The increased presence of these Aβ oligomers in AD patients inhibits insulin signaling pathways, leading to neuroinflammation and neurodegeneration through elevated Aβ concentrations and GSK3β-dependent hyperphosphorylation of tau [38]. The gene discussed is MAPT; the disease is Alzheimer disease.